Mizuho Markets Americas LLC Increases Stock Holdings in Cencora, Inc. $COR

Mizuho Markets Americas LLC boosted its position in shares of Cencora, Inc. (NYSE:COR) by 5.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 224,700 shares of the company’s stock after purchasing an additional 11,900 shares during the period. Cencora makes up 1.5% of Mizuho Markets Americas LLC’s holdings, making the stock its 16th largest holding. Mizuho Markets Americas LLC’s holdings in Cencora were worth $75,892,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Advisory Alpha LLC purchased a new stake in shares of Cencora in the fourth quarter worth $211,000. Axxcess Wealth Management LLC increased its stake in Cencora by 1,086.1% in the 4th quarter. Axxcess Wealth Management LLC now owns 117,047 shares of the company’s stock worth $39,533,000 after acquiring an additional 107,179 shares during the last quarter. Trajan Wealth LLC raised its holdings in shares of Cencora by 6.0% in the 4th quarter. Trajan Wealth LLC now owns 143,475 shares of the company’s stock valued at $48,459,000 after acquiring an additional 8,169 shares in the last quarter. Algebris UK Ltd. raised its holdings in shares of Cencora by 5.7% in the 4th quarter. Algebris UK Ltd. now owns 5,751 shares of the company’s stock valued at $1,943,000 after acquiring an additional 311 shares in the last quarter. Finally, Leonteq Securities AG bought a new stake in shares of Cencora during the 4th quarter valued at about $58,000. 97.52% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

COR has been the topic of several research analyst reports. Citigroup decreased their price objective on shares of Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Robert W. Baird dropped their target price on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a research report on Thursday, May 7th. Leerink Partners reissued an “outperform” rating on shares of Cencora in a research note on Tuesday, March 17th. William Blair initiated coverage on shares of Cencora in a report on Tuesday, April 28th. They issued a “market perform” rating on the stock. Finally, Morgan Stanley set a $342.00 price objective on shares of Cencora in a report on Friday, May 8th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $380.25.

Cencora Price Performance

Shares of Cencora stock opened at $275.01 on Friday. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. The business’s 50 day simple moving average is $305.70 and its two-hundred day simple moving average is $336.77. The stock has a market capitalization of $53.51 billion, a P/E ratio of 21.09, a price-to-earnings-growth ratio of 1.22 and a beta of 0.64. Cencora, Inc. has a one year low of $244.82 and a one year high of $377.54.

Cencora (NYSE:COR) last released its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The company had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. During the same period last year, the company posted $4.42 EPS. The business’s revenue for the quarter was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Analysts forecast that Cencora, Inc. will post 17.76 EPS for the current year.

Cencora declared that its board has initiated a share repurchase plan on Thursday, May 21st that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the company to buy up to 3.9% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

Cencora Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be given a dividend of $0.60 per share. The ex-dividend date of this dividend is Friday, May 15th. This represents a $2.40 annualized dividend and a yield of 0.9%. Cencora’s dividend payout ratio is presently 18.40%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.